| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |